Stock listing
OTC:ISCO International Stem Cell Corporation Stock
Follow International Stem Cell Corporation into a list and get an email when it puts out news.
Share price · OTC:ISCO
$0.16 USD +0.00 (+0.3%)
Close on Nov 18, 2026
- Day range
- $0.16 – $0.16 USDNov 18, 2026
- Volume
- 1,248 sharesNov 18, 2026
- Market cap
- $1.28M USDAt the close on Nov 18, 2026 · price × 8.00M shares outstanding
- 52-week range
- $0.12 – $0.54 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
- Traded on an average day
- $10,481 USDMedian day 3,100 shares · 4 days with no trades · last 3 months, Aug 18, 2026 – Nov 18, 2026

Daily closes
Last 3 months, Aug 18, 2026 – Nov 18, 2026 · OTC:ISCO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.16 | +0.001 | +0.3% | $0.16 | $0.16 | $0.16 | 1,248 | |
| $0.159 | +0.004 | +2.6% | $0.167 | $0.167 | $0.159 | 1,154 | |
| $0.155 | 0.00 | 0.0% | $0.155 | $0.155 | $0.155 | 28,563 | |
| $0.155 | +0.01 | +6.9% | $0.159 | $0.161 | $0.155 | 5,062 | |
| $0.145 | 0.00 | 0.0% | $0.145 | $0.145 | $0.145 | 24,996 | |
| $0.145 | +0.005 | +3.6% | $0.145 | $0.145 | $0.145 | 400 | |
| $0.14 | 0.00 | 0.0% | $0.14 | $0.14 | $0.14 | 4 | |
| $0.14 | -0.04 | -22.2% | $0.16 | $0.18 | $0.14 | 49,200 | |
| $0.18 | +0.03 | +20.0% | $0.17 | $0.18 | $0.17 | 2,800 | |
| $0.15 | +0.01 | +7.1% | $0.15 | $0.16 | $0.15 | 7,000 | |
| $0.14 | -0.01 | -6.7% | $0.14 | $0.14 | $0.14 | 400 | |
| $0.15 | 0.00 | 0.0% | $0.19 | $0.19 | $0.14 | 38,900 | |
| $0.15 | -0.03 | -16.7% | $0.18 | $0.18 | $0.14 | 200,400 | |
| $0.18 | -0.08 | -30.8% | $0.26 | $0.26 | $0.17 | 242,200 | |
| $0.26 | -0.023 | -8.1% | $0.29 | $0.29 | $0.26 | 26,380 | |
| $0.283 | +0.003 | +1.1% | $0.27 | $0.29 | $0.27 | 26,456 | |
| $0.28 | +0.01 | +3.7% | $0.28 | $0.29 | $0.28 | 6,500 | |
| $0.27 | +0.01 | +3.8% | $0.27 | $0.27 | $0.27 | 6,700 | |
| $0.26 | +0.01 | +4.0% | $0.26 | $0.26 | $0.26 | 600 | |
| $0.25 | -0.03 | -10.7% | $0.27 | $0.29 | $0.25 | 10,200 | |
| $0.28 | 0.00 | 0.0% | $0.28 | $0.28 | $0.28 | 1,300 | |
| $0.28 | +0.01 | +3.7% | $0.29 | $0.29 | $0.28 | 300 | |
| $0.27 | -0.02 | -6.9% | $0.26 | $0.28 | $0.26 | 800 | |
| $0.29 | +0.01 | +3.6% | $0.28 | $0.29 | $0.28 | 4,500 | |
| $0.28 | -0.01 | -3.4% | $0.28 | $0.29 | $0.28 | 1,200 | |
| $0.29 | 0.00 | 0.0% | $0.29 | $0.29 | $0.29 | 2,500 | |
| $0.29 | -0.01 | -3.3% | $0.29 | $0.29 | $0.29 | 1,000 | |
| $0.30 | -0.01 | -3.2% | $0.30 | $0.33 | $0.30 | 9,200 | |
| $0.31 | -0.02 | -6.1% | $0.30 | $0.31 | $0.30 | 300 | |
| $0.33 | 0.00 | 0.0% | $0.31 | $0.33 | $0.30 | 3,100 | |
| $0.33 | -0.02 | -5.7% | $0.33 | $0.33 | $0.33 | 100 | |
| $0.35 | 0.00 | 0.0% | $0.35 | $0.35 | $0.35 | 0 | |
| $0.35 | +0.03 | +9.4% | $0.32 | $0.35 | $0.32 | 3,100 | |
| $0.32 | -0.01 | -3.0% | $0.36 | $0.36 | $0.32 | 600 | |
| $0.33 | 0.00 | 0.0% | $0.34 | $0.34 | $0.28 | 155,400 | |
| $0.33 | 0.00 | 0.0% | $0.33 | $0.33 | $0.33 | 0 | |
| $0.33 | 0.00 | 0.0% | $0.33 | $0.33 | $0.33 | 500 | |
| $0.33 | -0.04 | -10.8% | $0.35 | $0.35 | $0.33 | 8,300 | |
| $0.37 | +0.05 | +15.6% | $0.35 | $0.37 | $0.35 | 500 | |
| $0.32 | -0.06 | -15.8% | $0.37 | $0.37 | $0.32 | 51,900 | |
| $0.38 | +0.02 | +5.6% | $0.44 | $0.52 | $0.34 | 460,300 | |
| $0.36 | 0.00 | 0.0% | $0.32 | $0.36 | $0.32 | 34,000 | |
| $0.36 | -0.01 | -2.7% | $0.40 | $0.45 | $0.36 | 28,600 | |
| $0.37 | +0.04 | +12.1% | $0.40 | $0.53 | $0.36 | 55,000 | |
| $0.33 | -0.09 | -21.4% | $0.33 | $0.33 | $0.33 | 100 | |
| $0.42 | 0.00 | 0.0% | $0.42 | $0.42 | $0.42 | 0 | |
| $0.42 | +0.03 | +7.7% | $0.42 | $0.42 | $0.42 | 300 | |
| $0.39 | +0.01 | +2.6% | $0.31 | $0.40 | $0.31 | 2,500 | |
| $0.38 | 0.00 | 0.0% | $0.38 | $0.38 | $0.38 | 0 | |
| $0.38 | +0.03 | +8.6% | $0.36 | $0.38 | $0.30 | 11,900 | |
| $0.35 | -0.14 | -28.6% | $0.35 | $0.43 | $0.21 | 322,800 | |
| $0.49 | 0.00 | 0.0% | $0.49 | $0.49 | $0.42 | 2,100 | |
| $0.49 | +0.01 | +2.1% | $0.49 | $0.49 | $0.49 | 200 | |
| $0.48 | -0.02 | -4.0% | $0.48 | $0.48 | $0.48 | 1,000 | |
| $0.50 | 0.00 | 0.0% | $0.46 | $0.50 | $0.46 | 4,600 | |
| $0.50 | +0.05 | +11.1% | $0.40 | $0.50 | $0.30 | 51,500 | |
| $0.45 | -0.06 | -11.8% | $0.46 | $0.46 | $0.42 | 1,400 | |
| $0.51 | +0.02 | +4.1% | $0.51 | $0.54 | $0.45 | 17,000 | |
| $0.49 | +0.09 | +22.5% | $0.40 | $0.52 | $0.37 | 93,000 |
Splits
1 split · OTC:ISCO · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-150 | Consolidation |
- Ticker
- OTC:ISCO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
International Stem Cell Corporation on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- Decks
- 4 decks · latest Nov 27, 2019
Valuation
EV/sales −2.0× against a median of 29.8×: 2nd lowest of 5 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 18, 2026
- Enterprise value
- −$18.76M USD
- P/E
- 0.1×
- EV/sales
- −2.0×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.1×
- Gross margin
- 54.5%
- Operating margin
- −6.4%
- Net margin
- 222.6%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- -0.52
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| International Stem Cell Corporation · OTC:ISCO | US$1.28M | −US$18.76M | 0.1× | −2.0× | n/a | 0.1× | 222.6% | 0.0× | -0.52 |
| Jupiter Neurosciences, Inc. · NASDAQ:JUNS | US$1.63M | US$1.33M | n/a | 16.9× | n/a | n/a | n/a | n/a | 1.88 |
| Kairos Pharma, Ltd. · AMEX:KAPA | US$1.48M | −US$1.65M | n/a | n/a | n/a | 0.4× | n/a | 0.0× | 1.36 |
| BioRestorative Therapies, Inc. · NASDAQ:BRTX | US$1.45M | −US$2.11M | n/a | −5.9× | n/a | 0.5× | n/a | 0.0× | 1.81 |
| Nutra Pharma Corp. · OTC:NPHC | US$1.43M | US$13.99M | n/a | 87.0× | n/a | n/a | n/a | n/a | n/a |
| Aptevo Therapeutics Inc. · NASDAQ:APVO | US$1.40M | −US$2.88M | n/a | n/a | n/a | 0.4× | n/a | 1.0× | 0.93 |
| Agentix Corp. · OTC:AGTX | US$1.35M | US$1.34M | n/a | n/a | n/a | n/a | n/a | n/a | -0.73 |
| Clearmind Medicine Inc. · NASDAQ:CMND | US$1.33M | −US$9.01M | n/a | n/a | n/a | 0.2× | n/a | 0.0× | 0.29 |
| Artelo Biosciences, Inc. · NASDAQ:ARTL | US$1.30M | US$1.34M | n/a | n/a | n/a | 0.2× | n/a | 0.0× | 1.36 |
| SureNano Science Ltd · CSE:SURE | US$1.17M | US$672,321 | n/a | n/a | n/a | 0.3× | n/a | 0.0× | 0.25 |
| Valion Bio, Inc. · NASDAQ:VBIO | US$1.04M | US$16.34M | n/a | 42.8× | n/a | 0.2× | n/a | 4.1× | 1.11 |
| Median of the others | US$1.37M | US$1.00M | 29.8× | 0.3× | 0.0× | 1.11 |
Team and board
Officers
| Officer | Role |
|---|---|
| Andrey Semechkin | Chief Executive Officer & Co-Chairman of the Board |
| Russell Kern | Executive Vice President, Chief Scientific Officer & Principal Financial Officer |
Board
| Director | Role |
|---|---|
| Andrey Semechkin | Chief Executive Officer & Co-Chairman of the Board |
| Donald Wright | Co-Chairman |
| Paul Maier | Independent Director |
| Russell Kern | Executive Vice President, Chief Scientific Officer & Principal Financial Officer |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2025 | Aug 14, 2025 | 0.0% |
| Q1 2025 | Jun 11, 2025 · After close | 0.0% |
| Q4 2024 | Feb 26, 2025 | 0.0% |
| Q3 2024 | Nov 29, 2024 | +11.1% |
| Q2 2024 | Aug 14, 2024 | 0.0% |
| Q1 2024 | May 14, 2024 · After close | 0.0% |
| Q3 2023 | Nov 16, 2023 | 0.0% |
| Q2 2023 | Aug 16, 2023 | 0.0% |
| Q1 2023 | Apr 11, 2023 | −9.1% |
| Q3 2022 | Nov 14, 2022 · After close | 0.0% |
All 17 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q2 2022 | Aug 12, 2022 · Before open | −18.4% |
| Q1 2022 | May 20, 2022 | −10.0% |
| Q4 2021 | Mar 2, 2022 | 0.0% |
| Quarter to Sep 30, 2021 | Nov 18, 2021 | 0.0% |
| Quarter to Jun 30, 2021 | Aug 18, 2021 | 0.0% |
| Quarter to Mar 31, 2021 | May 14, 2021 | −11.1% |
| Quarter to Dec 31, 2020 | Mar 30, 2021 · After close | 0.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (November 2019) | Investor deck | 16 slides | Nov 27, 2019 |
| Investor Presentation (October 2018) | Investor deck | 19 slides | October 2018 |
| Investor Presentation (December 2015) | Investor deck | 12 slides | Dec 17, 2015 |
| Investor Presentation (January 2014) | Investor deck | 22 slides | Jan 21, 2014 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.10M | 9.09M | 7.79M | 8.18M | 7.18M | 7.13M | 9.47M | 11.1M | 7.46M | 7.17M |
| Cost of revenue | 4.03M | 3.76M | 3.18M | 3.27M | 2.94M | 2.78M | 3.93M | 4.07M | 2.12M | 1.94M |
| Gross profit | 5.07M | 5.32M | 4.61M | 4.91M | 4.24M | 4.35M | 5.54M | 7.02M | 5.33M | 5.22M |
| Research and development | 684.0K | 657.0K | 511.0K | 492.0K | 695.0K | 988.0K | 1.39M | 2.40M | 2.66M | 2.86M |
| Operating income | -267.0K | -68.0K | -663.0K | -183.0K | -1.92M | -2.82M | -5.73M | -3.47M | -4.94M | -4.85M |
| Depreciation and amortization | 219.0K | 206.0K | 194.0K | 218.0K | 262.0K | 253.0K | 285.0K | 308.0K | 326.0K | 331.0K |
| EBITDA | -48.0K | 138.0K | -469.0K | 35.0K | -1.66M | -2.56M | -5.44M | -3.17M | -4.62M | -4.52M |
| Interest expense | 151.0K | 145.0K | 139.0K | 135.0K | 128.0K | 113.0K | 77.0K | 48.0K | 59.0K | 6.00K |
| Income before tax | -418.0K | -209.0K | -131.0K | -331.0K | -2.13M | -6.07M | -1.08M | |||
| Income tax | 0 | 0 | 0 | 0 | 0 | |||||
| Net income | -418.0K | -209.0K | -131.0K | -331.0K | -899.0K | -2.72M | -4.26M | -2.13M | -6.07M | -1.08M |
| Earnings per share, basic | -0.05 | -0.03 | -0.02 | -0.04 | -0.11 | -0.36 | -0.57 | -0.33 | -1.46 | -0.34 |
| Earnings per share, diluted | -0.05 | -0.03 | -0.02 | -0.04 | -0.11 | -0.36 | -0.57 | -0.33 | -1.46 | -0.34 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 793.0K | 1.23M | 1.59M | 742.0K | 171.0K | 689.0K | 484.0K | 1.07M | 304.0K | 110.0K |
| Receivables | 5.00K | 1.06M | 574.0K | 747.0K | 844.0K | 403.0K | 1.51M | 651.0K | 465.0K | 574.0K |
| Inventory | 100.0K | 1.15M | 1.26M | 1.38M | 1.18M | 917.0K | 1.25M | 1.50M | 1.31M | 1.39M |
| Current assets | 3.41M | 3.56M | 3.52M | 2.96M | 2.33M | 2.18M | 3.45M | 3.77M | 2.85M | 2.49M |
| Property, plant and equipment | 21.0K | 257.0K | 215.0K | 248.0K | 384.0K | 534.0K | 668.0K | 469.0K | 321.0K | 396.0K |
| Total assets | 4.82M | 5.17M | 5.39M | 5.13M | 4.95M | 5.29M | 6.62M | 7.80M | 6.86M | 7.04M |
| Accounts payable | 109.0K | 186.0K | 364.0K | 322.0K | 508.0K | 360.0K | 654.0K | 458.0K | 830.0K | 841.0K |
| Current liabilities | 4.58M | 4.69M | 4.83M | 4.63M | 4.28M | 1.48M | 1.91M | 5.08M | 4.80M | 3.60M |
| Total liabilities | 4.58M | 4.80M | 5.28M | 5.36M | 5.23M | 5.32M | 5.21M | 5.26M | 4.80M | |
| Shareholders' equity | -4.06M | -3.93M | -4.19M | -4.52M | -4.59M | -4.33M | -2.89M | 2.54M | 2.06M | 3.44M |
| Shares outstanding | 8.00M | 8.00M | 8.00M | 8.00M | 8.00M | 7.54M | 7.54M | 6.93M | 6.06M | 3.95M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 8.00K | 13.0K | 929.0K | 332.0K | -1.30M | -341.0K | -1.40M | -1.08M | -2.14M | -4.20M |
| Capital spending | -43.0K | -166.0K | -80.0K | -1.00K | -23.0K | -28.0K | -164.0K | -185.0K | -112.0K | -231.0K |
| Free cash flow | -35.0K | -153.0K | 849.0K | 331.0K | -1.32M | -369.0K | -1.56M | -1.27M | -2.25M | -4.43M |
| Cash from investing | -45.0K | -171.0K | -83.0K | -11.0K | -45.0K | -108.0K | -494.0K | -661.0K | -864.0K | -943.0K |
| Cash from financing | -200.0K | -200.0K | 250.0K | 824.0K | 654.0K | 1.30M | 2.51M | 3.20M | 4.72M | |
| Change in cash | -237.0K | -358.0K | 846.0K | 571.0K | -518.0K | 205.0K | -591.0K | 771.0K | 194.0K | -422.0K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 20, 2026 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 17, 2026 | Explanation request | SEC |
| 4 · Change in ownership | Sep 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 15, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 11, 2026 | Other filings | SEC |
| 8-K · Current report | Sep 8, 2026 | Acquisition or disposal | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
| DEF 14C | Aug 4, 2026 | Meeting notice | SEC |
| PRE 14C | Jul 24, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jul 15, 2026 | Material contract | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Jun 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 23, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 12, 2026 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 14, 2026 | Quarterly report | SEC |
| ARS · Annual report to shareholders | Apr 29, 2026 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 29, 2026 | Meeting notice | SEC |
| 10-K · Annual report | Mar 30, 2026 | Annual report | SEC |
| 8-K · Current report | Nov 18, 2025 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Nov 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Sep 16, 2025 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 4 · Change in ownership | Jun 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 20, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | May 14, 2025 | Quarterly report | SEC |
| ARS · Annual report to shareholders | Apr 24, 2025 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 24, 2025 | Meeting notice | SEC |
| 10-K · Annual report | Mar 28, 2025 | Annual report | SEC |
| 10-Q · Quarterly report | Nov 13, 2024 | Quarterly report | SEC |
| 8-K · Current report | Sep 16, 2024 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 13, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | May 14, 2024 | Quarterly report | SEC |
| ARS · Annual report to shareholders | Apr 26, 2024 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 25, 2024 | Meeting notice | SEC |
| S-8 · Registration statement for employee plans | Mar 28, 2024 | Offer document | SEC |
| 10-K · Annual report | Mar 28, 2024 | Annual report | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | Nov 8, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 8, 2023 | Insider trade | SEC |
| DEF 14C | Sep 27, 2023 | Meeting notice | SEC |
| 8-K · Current report | Sep 18, 2023 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 11, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jun 21, 2023 | Meeting outcome | SEC |
| 4 · Change in ownership | Jun 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | May 12, 2023 | Quarterly report | SEC |
| ARS · Annual report to shareholders | Apr 28, 2023 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 28, 2023 | Meeting notice | SEC |
| 10-K · Annual report | Mar 30, 2023 | Annual report | SEC |
| 8-K · Current report | Mar 16, 2023 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 14, 2022 | Quarterly report | SEC |
| 8-K · Current report | Sep 16, 2022 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 12, 2022 | Quarterly report | SEC |
| 8-K · Current report | Jun 13, 2022 | Meeting outcome | SEC |
| 4 · Change in ownership | Jun 10, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jun 10, 2022 | Insider trade | SEC |
| 10-Q · Quarterly report | May 13, 2022 | Quarterly report | SEC |
| 8-K · Current report | Apr 29, 2022 | Management or board change | SEC |
| DEF 14A · Proxy statement | Apr 27, 2022 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 26, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Apr 26, 2022 | Insider trade | SEC |
| 10-K · Annual report | Mar 29, 2022 | Annual report | SEC |
| 8-K · Current report | Mar 3, 2022 | Material contract | SEC |
| 8-K · Current report | Feb 1, 2022 | Management or board change | SEC |
| 8-K · Current report | Jan 14, 2022 | Material contract | SEC |
| 8-K · Current report | Dec 28, 2021 | Current report | SEC |
| 10-Q · Quarterly report | Nov 12, 2021 | Quarterly report | SEC |
| 8-K · Current report | Nov 1, 2021 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 13, 2021 | Quarterly report | SEC |
| 8-K · Current report | Jun 30, 2021 | Current report | SEC |
| 8-K · Current report | Jun 14, 2021 | Meeting outcome | SEC |
| 4 · Change in ownership | Jun 11, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 11, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 11, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 11, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 11, 2021 | Insider trade | SEC |
| 10-Q · Quarterly report | May 14, 2021 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Apr 29, 2021 | Meeting notice | SEC |
| 10-K · Annual report | Mar 30, 2021 | Annual report | SEC |
| 8-K · Current report | Mar 8, 2021 | Material contract | SEC |
| 8-K · Current report | Jan 19, 2021 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 12, 2020 | Quarterly report | SEC |
| 10-Q · Quarterly report | Aug 12, 2020 | Quarterly report | SEC |
| 8-K · Current report | Jun 29, 2020 | Meeting outcome | SEC |
| 4/A · Change in ownership, amended | Jun 26, 2020 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jun 26, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2020 | Insider trade | SEC |
| 10-Q · Quarterly report | Jun 19, 2020 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Jun 1, 2020 | Meeting notice | SEC |
| 10-K · Annual report | May 29, 2020 | Annual report | SEC |
| 8-K · Current report | May 13, 2020 | Current report | SEC |
| NT 10-K · Late filing notice | May 13, 2020 | Explanation request | SEC |
| 8-K · Current report | Apr 28, 2020 | Current report | SEC |
| 8-K · Current report | Mar 30, 2020 | Current report | SEC |
| 8-K · Current report | Dec 19, 2019 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 12, 2019 | Quarterly report | SEC |
| 10-Q · Quarterly report | Aug 26, 2019 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Aug 14, 2019 | Explanation request | SEC |
| 8-K · Current report | Jul 30, 2019 | Current report | SEC |
| 8-K · Current report | Jun 7, 2019 | Meeting outcome | SEC |
| 4 · Change in ownership | Jun 5, 2019 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2019 | Insider trade | SEC |
| 10-Q · Quarterly report | May 15, 2019 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Apr 30, 2019 | Meeting notice | SEC |
| 8-K · Current report | Apr 23, 2019 | Material contract | SEC |
| 4 · Change in ownership | Apr 22, 2019 | Insider trade | SEC |
| 10-K · Annual report | Apr 12, 2019 | Annual report | SEC |
| NT 10-K · Late filing notice | Apr 1, 2019 | Explanation request | SEC |
| SC 13D/A · Big-stake notice, amended | Mar 6, 2019 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 4, 2019 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2019 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2019 | Insider trade | SEC |
| 8-K · Current report | Jan 23, 2019 | Material contract | SEC |
| 4 · Change in ownership | Jan 22, 2019 | Insider trade | SEC |
| 4 · Change in ownership | Dec 6, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Dec 6, 2018 | Insider trade | SEC |
| 8-K · Current report | Nov 14, 2018 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 14, 2018 | Quarterly report | SEC |
| 4 · Change in ownership | Oct 3, 2018 | Insider trade | SEC |
| 8-K · Current report | Oct 3, 2018 | Financing | SEC |
| 4/A · Change in ownership, amended | Sep 27, 2018 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Sep 27, 2018 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Sep 27, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Aug 22, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Aug 21, 2018 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Aug 21, 2018 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Aug 21, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2018 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Aug 15, 2018 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 14, 2018 | Quarterly report | SEC |
| 4 · Change in ownership | Jul 17, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Jul 12, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Jun 28, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Jun 27, 2018 | Insider trade | SEC |
| 8-K · Current report | Jun 27, 2018 | Meeting outcome | SEC |
| 4 · Change in ownership | Jun 25, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2018 | Insider trade | SEC |
| 8-K · Current report | Jun 4, 2018 | Material contract | SEC |
| 10-Q · Quarterly report | May 21, 2018 | Quarterly report | SEC |
| 4 · Change in ownership | May 16, 2018 | Insider trade | SEC |
| 8-K · Current report | May 16, 2018 | Material contract | SEC |
| NT 10-Q · Late filing notice | May 15, 2018 | Explanation request | SEC |
| DEF 14A · Proxy statement | Apr 30, 2018 | Meeting notice | SEC |
| 10-K · Annual report | Apr 6, 2018 | Annual report | SEC |
| 4 · Change in ownership | Apr 4, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2018 | Insider trade | SEC |
| NT 10-K · Late filing notice | Apr 2, 2018 | Explanation request | SEC |
| 4 · Change in ownership | Mar 14, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Mar 14, 2018 | Insider trade | SEC |
| 8-K · Current report | Mar 8, 2018 | Material contract | SEC |
| RW · Request to withdraw a registration | Mar 8, 2018 | Other filings | SEC |
| 4 · Change in ownership | Feb 22, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Feb 22, 2018 | Insider trade | SEC |
| 8-K · Current report | Feb 21, 2018 | Management or board change | SEC |
| 4 · Change in ownership | Feb 1, 2018 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Jan 31, 2018 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 2, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2018 | Insider trade | SEC |
| 8-K · Current report | Dec 13, 2017 | Material contract | SEC |
| 4 · Change in ownership | Dec 12, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Dec 8, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Dec 8, 2017 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 13, 2017 | Quarterly report | SEC |
| 4 · Change in ownership | Oct 2, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2017 | Insider trade | SEC |
| 8-K · Current report | Sep 6, 2017 | Material contract | SEC |
| 4 · Change in ownership | Aug 30, 2017 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 30, 2017 | Insider trade | SEC |
| 8-K · Current report | Aug 25, 2017 | Management or board change | SEC |
| 10-Q · Quarterly report | Aug 11, 2017 | Quarterly report | SEC |
| 4 · Change in ownership | Jul 5, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Jul 5, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Jul 5, 2017 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | Jun 15, 2017 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Jun 9, 2017 | Offer document | SEC |
| 8-K · Current report | Jun 8, 2017 | Material contract | SEC |
| 8-K · Current report | Jun 6, 2017 | Meeting outcome | SEC |
| 4 · Change in ownership | Jun 2, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Jun 1, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Jun 1, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Jun 1, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Jun 1, 2017 | Insider trade | SEC |
| 4 · Change in ownership | May 24, 2017 | Insider trade | SEC |
| 10-Q · Quarterly report | May 15, 2017 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Apr 27, 2017 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 3, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2017 | Insider trade | SEC |
| 10-K · Annual report | Mar 31, 2017 | Annual report | SEC |
This page holds 200 of 827 filings. Open Filings
Cap table
Built by 6ix from International Stem Cell Corporation’s releases · as of Jun 30, 2026
- Common shares
- 8,004,389
- Fully diluted
- 8,004,389
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 8,004,389 | Jun 30, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Jun 30, 2026 | 8,004,389 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Charles J. Casamento Other companies: GT Biopharma, Inc. (Independent Director · Since at least May 1, 2023); Eton Pharmaceuticals, Inc. (Director · Since at least Nov 9, 2018); Relmada Therapeutics, Inc. (Chairman of the Board · Since at least Oct 20, 2017); PaxMedica, Inc. (Director · Oct 1, 2022 – Mar 12, 2024 · Past); GridAI Technologies Corp. (Director · Mar 3, 2017 – Jan 2, 2024 · Past) | Director · Mar 31, 2016 – Jun 21, 2018 · Past |
| Paul V. Maier Other companies: Eton Pharmaceuticals, Inc. (Eton Pharmaceutical Audit Committee Chairman · Since at least May 3, 2021); Ambrx Biopharma Inc. (Director · Jan 1, 2023 – Mar 7, 2024 · Past) | Independent Director · Since at least Jun 9, 2021 |
| Edward O Hunter Other companies: GEE Group Inc. (Director · Feb 23, 2009 – Feb 23, 2009 · Past) | Director · Jul 19, 2007 – Dec 29, 2008 · Past |
| James H Berglund Other companies: Accredited Home Lenders Holding Co (Director · Oct 12, 2007 – Oct 12, 2007 · Past) | Director · Mar 9, 2012 – Jun 20, 2013 · Past |
| Andrey Semechkin | Chief Executive Officer & Co-Chairman of the Board · Since at least Apr 25, 2022 |
| Donald Wright | Co-Chairman · Since at least Nov 5, 2026 |
| Jeff Krstich | Chief Executive Officer · Dec 28, 2006 – Dec 28, 2006 · Past |
| Mahnaz Ebrahimi | Chief Financial Officer · May 17, 2016 – May 31, 2017 · Past |
| Russell Kern | Executive Vice President, Chief Scientific Officer & Principal Financial Officer · Since at least Jun 9, 2021 |
| Sophia Garnette | VP, Legal Affairs & Operations · Aug 4, 2014 – Jun 9, 2021 · Past |
All 11 people
| Person | Seat |
|---|---|
| Wright Don | Director · Since at least Dec 29, 2008 |
Log in to ask 6ix AI your own questions about International Stem Cell Corporation.